NNOX is one of those volatile stocks that took the world by storm. If you don't like volatility, it is likely best to stay away from biotech or healthcare. That said, there are alot of expected catalysts. NNOX have been heavily shortened, and it is in the opinion of many that lots of market manipulation has been and is going on. The short interest is low and the borrow rate is high. Currently as I see it, the pattern is still incrementally upwards. Nanox has the catalyst of factory announcements, FDA approvals for both single and multisource, plus the commencement of "device leasing". Currently with 4 catalyst, three of them that are expected to be big, a target of $115 seems reasonable. Support levels should be picking up soon, and unless one wants to flip for few cents or dollars per share as profit, this currently seems much better suited for a long term position. That said, I am long. Everything I say is on an opinion based basis. Please do your own due diligence and proceed with caution. Opinions mentioned here aren't meant to warrant solicited financial advice.
Follow me on Tradingview :)
Also ->
Reach out: linkedin.com/in/gamer456148
For Consulting: aiquant.co
HedgePocket Beta: hedgepocket.com
Sovereign Trades Beta Signup: sovereign-trades.com
Also ->
Reach out: linkedin.com/in/gamer456148
For Consulting: aiquant.co
HedgePocket Beta: hedgepocket.com
Sovereign Trades Beta Signup: sovereign-trades.com
Publicaciones relacionadas
Exención de responsabilidad
La información y las publicaciones no constituyen, ni deben considerarse como, asesoramiento o recomendaciones financieras, de inversión, de trading u otro tipo, proporcionadas o respaldadas por TradingView. Obtenga más información en Condiciones de uso.
Follow me on Tradingview :)
Also ->
Reach out: linkedin.com/in/gamer456148
For Consulting: aiquant.co
HedgePocket Beta: hedgepocket.com
Sovereign Trades Beta Signup: sovereign-trades.com
Also ->
Reach out: linkedin.com/in/gamer456148
For Consulting: aiquant.co
HedgePocket Beta: hedgepocket.com
Sovereign Trades Beta Signup: sovereign-trades.com
Publicaciones relacionadas
Exención de responsabilidad
La información y las publicaciones no constituyen, ni deben considerarse como, asesoramiento o recomendaciones financieras, de inversión, de trading u otro tipo, proporcionadas o respaldadas por TradingView. Obtenga más información en Condiciones de uso.